Semax Where to Buy

Semax where to buy is a sourcing question before it is a shopping question, so this page runs as a checklist with a clock attached rather than as a list of names. Seven things are worth verifying, all of them from a chair, and together they take about ten minutes.

The clock matters because the usual reason people skip verification is that it sounds like a project. It is not. Six of the seven checks are single lines on a page you can already see, and the seventh is a document that either exists or does not. Everything here is research material for laboratory use and is not for human consumption, and the links below are affiliate links.

Semax where to buy: the criteria, and how long each takes to check

| Criterion | Where you look | Time | What a pass looks like | |---|---|---|---| | Batch-specific certificate | Product page, before the cart | 2 min | A document naming a laboratory, a batch number and an analysis date | | Purity against a specification | The certificate | 1 min | A percentage by HPLC set beside the specification it was judged against | | Identity | The certificate | 2 min | Mass confirmation for a seven-residue peptide, not a generic pass mark | | Endotoxin and sterility | The certificate | 2 min | A named method, a stated limit, and a result against that limit | | Domestic stock | Shipping page | 1 min | A dispatch cutoff written as a clock time | | Reversible payment | Checkout | 1 min | A card or processor that can be charged back | | No human-use claims | The listing copy | 1 min | Research-use language and no dosing guidance anywhere |

Seven lines, ten minutes, and no order placed yet. What follows is what each one is actually testing for.

The certificate, and specifically its batch number

A certificate without a batch number is a brochure. It can be republished for years without becoming untrue, because it never claimed to describe anything you could hold. The batch number is the join between the document and the vial, and it is the first thing to look for rather than the last.

Alongside it, a laboratory name and an analysis date. A named laboratory can be looked up. A date tells you whether the paperwork has kept pace with the stock, which is the failure that quietly appears at sellers who did everything right eighteen months ago.

Purity, set against something

A purity figure alone is a number without a verdict. What you want is the pair: the measured result and the specification it was judged against, so that the document is doing the grading rather than leaving it to you. A page that says high purity in body copy and publishes no chromatography has told you what it hopes rather than what it measured.

Identity, for a seven-residue peptide

Semax is a synthetic heptapeptide, the sequence Met-Glu-His-Phe-Pro-Gly-Pro, which is the ACTH(4-7) fragment with a Pro-Gly-Pro tail added to slow enzymatic breakdown. PubChem lists it under CID 9811102 with the formula C37H51N9O10S and a molecular weight of 813.9. Identity work on a certificate should be confirming that molecule against that expected mass.

This is worth knowing before you read anything else, because semax is constantly confused with the other Russian nootropic heptapeptide, which has a different sequence, a different mass and a different PubChem record. A listing that muddles the two has not been careless about a detail. It has been careless about the compound.

Endotoxin and sterility, which is the criterion FDA effectively wrote for you

FDA's compounding safety page, current as of 22 April 2026, says that compounded drugs containing semax may pose a risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities, and that the agency has no or limited safety information for the proposed routes. Read structurally rather than as a warning, that sentence names the tests. Aggregation and impurities are purity and identity questions. Immunogenicity on an injected route is where endotoxin and sterility data belong.

A pass here is a method, a limit and a result. The word tested, standing alone, is not a result.

The three checks that are not about the molecule at all

Domestic stock, meaning a dispatch cutoff stated as a clock time rather than a handling window in business days. A reversible payment method, because the recourse you have after a bad order is decided before you pay, not after. And research-use language with no dosing guidance, which sounds like a compliance detail and is really a signal about how the seller understands its own liability.

Where the Ascension listing lands against each criterion

Taking the criteria in order, and crediting only what the published document actually says.

The certificate exists, is batch-specific and is four pages, covering batch 30-05260628. Purity is reported at 99.886% against a specification of more than 98%, so the result carries its own verdict. Bacterial endotoxin is measured by kinetic chromogenic LAL to USP Chapter 85, against an E. coli O111:B4 standard with a detection range of 0.01 to 1.0 EU/mL, reporting under 0.20 EU/mL against an acceptance limit of 0.5 EU/mL. A microbial sterility screen returns no growth. The labelled quantity is 10 mg, lyophilised.

That is four of the seven cleared on paper, including the two that most certificates in this market never reach. The identity line is the one to read for yourself on the document rather than take from a summary, and it is worth doing while you have the file open.

On the remaining three: dispatch is stated as same day for orders placed before 2pm CST, which only domestic inventory supports; checkout is card-based, so a charge-back route exists; and the listing carries research-use language with no dosing guidance attached.

What none of that establishes is safety. A clean endotoxin result on one batch is a fact about that batch. FDA's position is that it lacks the human data to say whether this substance would cause harm if administered, and one good certificate does not supply that data. The certificate answers the question a buyer can actually ask, which is a smaller and more useful question.

The two criteria you cannot finish before you pay

Dispatch and packing are claims until an order tests them. The cutoff either holds or it does not, and a lyophilised powder either travels in a sealed vial with the label legible on arrival or it does not.

Both resolve within a week of the first order, which is why the first order is worth treating as the real check and the reading above as the filter that decides who gets one. If the parcel misses the stated cutoff by two days, that is a fact worth keeping. If it lands the next morning, the shipping page was accurate and can be trusted for the second order.

What arrives, and the first ten minutes with the box

A small padded parcel, and inside it a sealed glass vial holding a white or off-white lyophilised cake of 10 mg, usually under a crimped seal. It looks like almost nothing, because 10 mg of powder is almost nothing.

The first ten minutes are reading, not handling. Check the batch number on the label against the certificate you already opened, since a mismatch is the one problem that is easiest to raise on the day and impossible to raise a month later. Check that the seal is intact and the cake is where it should be rather than smeared up the side of the vial, which happens in transit and is cosmetic more often than not. Then get it into cold storage, sealed and dry and dark, and note the date you received it.

The same ten-minute habit applies across every research peptide, which is why the pre-cart checks that apply to Selank read as a close sibling to this page, and why the BPC-157 version of the same half hour lands on the same short list of things worth reading before paying.

The criterion most buyers skip

The regulatory line, which people either ignore or get wrong, usually by repeating that semax is FDA category 2.

The accurate version is a sequence. Semax was nominated for the 503A bulks list in 21 CFR 216.23. It was placed in category 2 while FDA evaluated it under its interim policies. The nomination was then withdrawn, which is not the same as being refused. Today it sits on no current FDA category list, and current category 2 contains six substances, none of which is semax.

Practically, this closes the compounding pharmacy route: a 503A pharmacy compounding from bulk needs the substance to be on that list, to have an applicable USP monograph, or to be a component of an approved drug, and semax is none of the three. It also means there is no FDA approval to appeal to. Russian registration is a fact about Russian regulation, not a Western efficacy finding, and the honest reading of a peptide with real registration abroad and no approval here is the same position Selank occupies, described there in full.

Common questions

Keep exploring

The ranking that applies weighted criteria to whole categories of seller, rather than one listing, is the Selank source ranking with its scoring published first. For the arithmetic behind a per-milligram figure once the code is applied, what a $47.50 vial costs after the code goes in works through the same structure on a neighbouring compound.